Compare Enzyme (MLN) vs Nibiru Chain (NIBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Nibiru Chain — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Nibiru Chain trades at Rp35.29 (market cap Rp55,17M, Rp4,69M 24h volume). The key difference: Enzyme is far larger — about 2.4× Nibiru Chain's market cap, and Nibiru Chain's supply is capped (954M / 1,5B NIBI (64%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Nibiru Chain for 7 Days on average.
| MLN | NIBI | |
|---|---|---|
Market Cap | Rp134,13M | Rp55,17M |
Volume (24h) | Rp104,56M | Rp4,69M |
Circulating Supply | 3,3M MLN | 954M / 1,5B NIBI (64%) |
Typical Hold Time | 28 Days | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Nibiru Chain (NIBI) currently holds a market cap of Rp55,17M with 64% of its 1.5M max supply in circulation. The asset shows limited trading activity with a 7-day average hold time, indicating low short-term speculation. Technical analysis reveals minimal price movement data available, while fundamental metrics suggest the project remains in early development stages with no significant protocol updates or ecosystem growth reported recently.
Overall outlook remains cautious due to extremely low market cap and limited liquidity. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low trading volume and regulatory uncertainty in the cryptocurrency space. Investors should monitor for any network upgrades or exchange listings that could improve liquidity.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Nibiru Chain
Nibiru Chain is a groundbreaking Layer 1 blockchain and smart contract ecosystem that offers exceptional throughput and unmatched security. Nibiru strives to be the most developer-friendly and user-friendly smart contract ecosystem, leading the way toward mainstream Web3 adoption. It achieves this by innovating at every layer of the technology stack, including dApp development, infrastructure, consensus mechanisms, a comprehensive developer toolkit, and value accrual.
Read more on NIBI →
